Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

18
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
18
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

20
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
20
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Discontinuation and reinitiation of mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction.

European journal of heart failure·2024
Same author

Phenotyping patients with chronic obstructive pulmonary disease and heart failure.

ESC heart failure·2024
Same author

Donor age and ischemic time in heart transplantation - implications for organ preservation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2024
Same author

Association of non-cardiac comorbidities and sex with long-term Re-hospitalization for heart failure.

European journal of internal medicine·2024
Same author

Trends in heart failure mortality in Sweden between 1997 and 2022.

European journal of heart failure·2024
Same author

A novel model of cardiovascular-kidney-metabolic syndrome combining unilateral nephrectomy and high-salt-sugar-fat diet in mice.

Lab animal·2024

相关实验视频

Updated: Jul 13, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.5K

心力衰竭登记 - - 未来的方向

Tymon Pol1, Patric Karlström2, Lars H Lund3

  • 1Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.

Journal of cardiology
|October 16, 2023
PubMed
概括
此摘要是机器生成的。

心力衰竭 (HF) 研究面临的挑战是由于亚型的理解和治疗实施的差距. 基于注册表的研究,包括随机试验,提供了一种务实的方法来解决HF护理中的未满足需求.

关键词:
临床注册表 临床注册表 临床注册表心脏衰竭是因为心脏衰竭.实施 实施 实施在RRCTT中,RRCT是指RRCT.

更多相关视频

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:15

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

75
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.7K

相关实验视频

Last Updated: Jul 13, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.5K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:15

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

75
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.7K

科学领域:

  • 心脏病学 心脏病学
  • 公共卫生 公共卫生
  • 临床研究方法论 临床研究方法论

背景情况:

  • 心力衰竭 (HF) 是一个重要的全球健康问题,尽管有进展,但患者的治疗结果仍然存在挑战.
  • 糟糕的结果与对HF亚型的不充分理解和现有治疗方法的不一致实施有关.

研究的目的:

  • 探索HF注册表如何增强临床研究和患者护理.
  • 展示基于注册表的研究在解决高频管理中的未满足需求方面的潜力.

主要方法:

  • 基于注册表的研究方法的审查,重点是基于注册表的随机临床试验 (rRCTs).
  • 利用来自瑞典心力衰竭注册和其他国际注册表的例子.
  • 讨论注册表作为战略,实施和选试验的平台.

主要成果:

  • 基于注册表的随机试验为传统的随机对照试验提供了务实且具有成本效益的替代方案.
  • 高频记录方便各种研究设计,包括战略和实施试验.
  • 注册表数据可以识别并帮助解决高频子类型理解和治疗应用中的差距.

结论:

  • 基于注册表的研究对改变HF临床研究和改善患者护理具有重大前景.
  • 利用HF注册表可以有效地解决了解和治疗各种HF亚型的关键未满足需求.
  • 将注册表纳入研究框架对于在全球推进高频管理至关重要.